Phibro Anl Htlh A Cm (PAHC) 20.83 $PAHC Phibro Animal

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 2:12 AM

Phibro Anl Htlh A Cm (PAHC) 20.83 $PAHC

Phibro Animal Health Corporation Declares Quarterly Dividend
GlobeNewswire - Tue Jul 26, 2:28AM CDT
The Board of Directors of Phibro Animal Health Corporation (Nasdaq

AHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 28, 2016, to stockholders of record at the close of business on September 7, 2016.
PAHC: 20.83 (+0.20)

MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 119.50 (+1.53), LDRH: 36.98 (-0.02), MDT: 88.06 (+0.43), PAHC: 20.83 (+0.20), MLAB: 114.10 (-1.53), NUVA: 63.29 (+1.09), BSX: 24.43 (+0.15), BABY: 39.18 (-0.15), SNN: 33.18 (-0.11), JNJ: 125.40 (+0.17), DXCM: 92.65 (+0.42), GWPH: 96.11 (+1.79), RMD: 69.85 (+0.97), WOOF: 70.40 (-0.94), ABT: 45.29 (+0.54), VIVO: 19.55 (+0.19), MASI: 52.93 (-0.04), TMO: 159.56 (+0.72), CYH: 12.58 (-0.19), HTWR: 57.96 (+0.02), FEIC: 106.45 (+0.03), ISRG: 693.87 (-1.89), CFMS: 6.92 (-0.05), STE: 71.41 (+0.46), STJ: 83.73 (+0.69), XRAY: 64.23 (+0.19), HOLX: 38.98 (+0.49)

Phibro Animal Health Corporation Submits Studies Reaffirming Safety of Mecadox(R)
GlobeNewswire - Mon Jul 11, 3:55PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) today submitted to the Food and Drug Administration (FDA) the findings of several new studies confirming the safety of carbadox, which is used to control bacterial diseases in pigs.
PAHC: 20.83 (+0.20)

Velocity Increases the Value of Cloud Applications for Phibro Animal Health
Marketwire Canada - Tue Jun 07, 7:38AM CDT
VCAMP(TM) Platform Takes JD Edwards to the Cloud, Adding Analytics and Proactive Alerting to Increase Agility and Reduce Risk
PAHC: 20.83 (+0.20)

Oregon livestock company wins trade-secret injunction
Capital Press - Sun Jun 05, 2:56PM CDT
SALEM, Ore. (AP) — An Oregon livestock company has won an injunction against a former employee accused of stealing trade secrets to start his own company in China.
PAHC: 20.83 (+0.20)

Phibro Animal Health Corporation Announces Gerald Carlson Retirement, Larry Miller Promotion
GlobeNewswire - Tue May 31, 3:15PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) today announced that Gerald Carlson, Chief Operating Officer, will retire after 14 years with Phibro, effective July 1, 2016.
PAHC: 20.83 (+0.20)

Phibro Animal Health Corporation to Participate at the Macquarie Global Emerging Leaders Conference
GlobeNewswire - Fri May 20, 3:00PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) Chief Financial Officer Richard Johnson will address financial analysts and portfolio managers at the Macquarie Global Emerging Leaders Conference.
PAHC: 20.83 (+0.20)

Phibro Animal (PAHC) Misses Q3 Earnings on Low Revenues
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:00AM CDT
Phibro (PAHC) ended the fiscal third quarter on a disappointing note, with its bottom line lagging the Zacks Consensus Estimate by a solid margin and its revenues failing to expand on a year-over-year basis.
SRDX: 27.06 (-0.37), PAHC: 20.83 (+0.20), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69)

Phibro posts 3Q profit
Automated Insights - Mon May 09, 6:22PM CDT
TEANECK, N.J. (AP) _ Phibro Animal Health Corp. (PAHC) on Monday reported fiscal third-quarter profit of $18.6 million.
PAHC: 20.83 (+0.20)

Phibro Animal Health Corporation Reports Third Quarter
GlobeNewswire - Mon May 09, 3:15PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) today announced its financial results for its third quarter ended March 31, 2016.
PAHC: 20.83 (+0.20)

Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Wed Apr 13, 12:00PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2016 Health Care Conference.
PAHC: 20.83 (+0.20)

Phibro Animal Declines as FDA Moves to Revoke Mecadox
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 12:50PM CDT
A recent reexamination by the FDA has led the authority to question Phibro Animal Health Corporation's (PAHC) Mecadox drug's safety.
PAHC: 20.83 (+0.20), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69), OFIX: 47.52 (+0.12)

Phibro Animal Health Corporation Reiterates Safety of Mecadox(R)
GlobeNewswire - Fri Apr 08, 1:59PM CDT
(NASDAQ

AHC) Today, the Food and Drug Administration (FDA) issued a press release stating its intention to take the initial steps in the process to rescind its approval of Mecadox(R) (carbadox). Mecadox has been approved and sold in the United States for more than 40 years and is a widely-used treatment for controlling bacterial diseases including Salmonella and swine dysentery. Mecadox is not used in human medicine and the class of drug is not considered a medically important antimicrobial. The approved Mecadox label requires a 42-day withdrawal period pre-harvesting, and to date we have not seen any hazardous residues of carbadox being detected from pig meat treated in accordance with the approved label.
PAHC: 20.83 (+0.20)

Phibro: Animal Health Grows amid Competition from Generics
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 1:35PM CDT
On Apr 7, 2016, we issued an updated research report on New Jersey-based Phibro Animal Health (PAHC).
CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), PAHC: 20.83 (+0.20), BAX: 48.50 (+0.48)

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2016 Quarterly Financial Results
GlobeNewswire - Wed Mar 30, 3:00PM CDT
Phibro Animal Health Corporation (NASDAQ

AHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 9, 2016.
PAHC: 20.83 (+0.20)

Phibro Animal Health (PAHC) in Focus: Stock Jumps 5.1%
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 7:35AM CDT
Phibro Animal Health Corporation (PAHC) was a big mover last session, as the company saw its shares rise over 5% on the day.
PAHC: 20.83 (+0.20), ATRC: 15.22 (+0.03)

Phibro (PAHC): Animal Health Grows Despite Currency Woes
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 1:30PM CDT
On Mar 17, 2016, we issued an updated research report on Phibro Animal Health Corporation (PAHC).
PAHC: 20.83 (+0.20), BAX: 48.50 (+0.48), HRC: 54.02 (+0.59), OSUR: 6.81 (-0.01)

Phibro Animal Health Corporation Announces Closing of Acquisition of Business of MVP Laboratories, Inc.
GlobeNewswire - Mon Jan 25, 3:30PM CST
Phibro Animal Health Corporation ("Phibro"

(NASDAQ

AHC) today announced it has completed its purchase of the assets of MVP Laboratories, Inc. ("MVP"

, a developer, manufacturer and marketer of livestock vaccines, vaccine adjuvants and other products based in Omaha, Nebraska. Phibro previously announced an agreement to purchase the assets of MVP Laboratories, Inc. on January 12, 2016.
PAHC: 20.83 (+0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Jackson Wang's Fantasy IP Hits Hong Kong Stage

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...